Last reviewed · How we verify
injectable poly-L-lactic acid
At a glance
| Generic name | injectable poly-L-lactic acid |
|---|---|
| Also known as | Sculptra Aesthetic, Sculptra, Poly-L-lactic acid |
| Sponsor | Williams Center Plastic Surgery Specialists |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prospective Clinical Investigation to Evaluate the Safety and Effectiveness of Juläine™ in Improving Gluteal Skin Laxity in Adults. (NA)
- A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients (PHASE1, PHASE2)
- Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars (NA)
- Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy (NA)
- Randomized Trial of Combination Treatment With Sofwave and Sculptra (PHASE4)
- Safety and Effectiveness of Sculptra 011611 for Improvement in Appearance of Gluteal Skin Irregularities (NA)
- MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology
- RESTRUCTURING THE MANDIBULAR ANGLE IN FACIAL AGING: A NOVEL TECNIQUE USING POLY-L-LACTIC ACID (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: